[go: up one dir, main page]

FR16C0003I2 - TRIGLYCERIDES AND ETHYL ESTERS OF PHENYLALKANOIC AND PHENYLALKENOIC ACIDS USEFUL IN THE TREATMENT OF DIFFERENT DISORDERS - Google Patents

TRIGLYCERIDES AND ETHYL ESTERS OF PHENYLALKANOIC AND PHENYLALKENOIC ACIDS USEFUL IN THE TREATMENT OF DIFFERENT DISORDERS

Info

Publication number
FR16C0003I2
FR16C0003I2 FR16C0003C FR16C0003C FR16C0003I2 FR 16C0003 I2 FR16C0003 I2 FR 16C0003I2 FR 16C0003 C FR16C0003 C FR 16C0003C FR 16C0003 C FR16C0003 C FR 16C0003C FR 16C0003 I2 FR16C0003 I2 FR 16C0003I2
Authority
FR
France
Prior art keywords
phenylalkanoic
triglycerides
treatment
ethyl esters
acids useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR16C0003C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRUSILOW ENTPR LLC
Brusilow Enterprises LLC
Original Assignee
BRUSILOW ENTPR LLC
Brusilow Enterprises LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23519346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR16C0003(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by BRUSILOW ENTPR LLC, Brusilow Enterprises LLC filed Critical BRUSILOW ENTPR LLC
Publication of FR16C0003I1 publication Critical patent/FR16C0003I1/fr
Application granted granted Critical
Publication of FR16C0003I2 publication Critical patent/FR16C0003I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR16C0003C 1995-02-07 2016-02-03 TRIGLYCERIDES AND ETHYL ESTERS OF PHENYLALKANOIC AND PHENYLALKENOIC ACIDS USEFUL IN THE TREATMENT OF DIFFERENT DISORDERS Active FR16C0003I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38493595A 1995-02-07 1995-02-07
PCT/US1996/000940 WO1996024571A1 (en) 1995-02-07 1996-02-06 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders

Publications (2)

Publication Number Publication Date
FR16C0003I1 FR16C0003I1 (en) 2016-03-25
FR16C0003I2 true FR16C0003I2 (en) 2016-06-24

Family

ID=23519346

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0003C Active FR16C0003I2 (en) 1995-02-07 2016-02-03 TRIGLYCERIDES AND ETHYL ESTERS OF PHENYLALKANOIC AND PHENYLALKENOIC ACIDS USEFUL IN THE TREATMENT OF DIFFERENT DISORDERS

Country Status (9)

Country Link
US (3) US5968979A (en)
EP (1) EP0858441B1 (en)
AT (1) ATE201013T1 (en)
AU (1) AU4858796A (en)
CA (1) CA2212047C (en)
DE (1) DE69612755T2 (en)
ES (1) ES2157422T3 (en)
FR (1) FR16C0003I2 (en)
WO (1) WO1996024571A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642543B1 (en) 2000-09-26 2003-11-04 The Board Of Trustees Of The Leland Stanford Junior University Thin and thick gate oxide transistors on a functional block of a CMOS circuit residing within the core of an IC chip
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20040229948A1 (en) * 2002-04-12 2004-11-18 Summar Marshall L. Method for preventing hepatic encephalopathic episodes
US20030195255A1 (en) * 2002-04-12 2003-10-16 Summar Marshall L. Method for treating hepatic encephalopathies
EP1511477A4 (en) 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
CA2506504A1 (en) 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US20090260743A1 (en) * 2003-11-21 2009-10-22 William David Mawby Tire manufacturing method for improving the uniformity of a tire
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
CA2735218A1 (en) * 2008-04-29 2009-11-05 Ucyclyd Pharma, Inc. Methods of treatment using ammonia-scavenging drugs
ES2593378T3 (en) * 2008-08-29 2016-12-09 Horizon Therapeutics, Llc Methods of treatment using ammonia sequestration drugs
AU2012316750B2 (en) 2011-09-30 2017-08-31 Immedica Pharma Ab Methods of therapeutic monitoring of nitrogen scavenging drugs
MX365302B (en) 2012-04-20 2019-05-29 Horizon Therapeutics Llc Methods of therapeutic monitoring of phenylacetic acid prodrugs.
DK2922576T3 (en) 2012-11-21 2018-01-15 Horizon Therapeutics Llc PROCEDURES FOR THE ADMINISTRATION AND EVALUATION OF NITROGEN RINSE MEDICINES FOR TREATING HEPATIC ENCYPHALOPATHY
SI2986325T1 (en) 2013-10-14 2020-02-28 Immedica Pharma Ab Methods of treating urea cycle disorders
IN2013MU03442A (en) 2013-10-30 2015-07-17 Lupin Ltd
CA2929688C (en) 2013-11-14 2023-06-13 Ultragenyx Pharmaceutical Inc. Solid compositions of triglycerides and uses thereof
ES2861594T3 (en) 2014-04-30 2021-10-06 Univ Johns Hopkins Compositions of dendrimers and their use in the treatment of diseases of the eye
US10918720B2 (en) 2014-08-13 2021-02-16 The Johns Hopkins University Selective dendrimer delivery to brain tumors
JP7088473B2 (en) 2015-10-29 2022-06-21 ザ・ジョンズ・ホプキンス・ユニバーシティー Compositions and Methods for the Treatment of Peroxisome Disorders and Leukodystrophy
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
US11612660B2 (en) 2019-12-04 2023-03-28 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Also Published As

Publication number Publication date
ATE201013T1 (en) 2001-05-15
FR16C0003I1 (en) 2016-03-25
DE69612755T2 (en) 2001-08-23
CA2212047A1 (en) 1996-08-15
EP0858441A4 (en) 1998-08-19
AU4858796A (en) 1996-08-27
US6083984A (en) 2000-07-04
WO1996024571A1 (en) 1996-08-15
US5968979A (en) 1999-10-19
EP0858441A1 (en) 1998-08-19
ES2157422T3 (en) 2001-08-16
EP0858441B1 (en) 2001-05-09
US6060510A (en) 2000-05-09
CA2212047C (en) 2010-11-16
DE69612755D1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
FR16C0003I2 (en) TRIGLYCERIDES AND ETHYL ESTERS OF PHENYLALKANOIC AND PHENYLALKENOIC ACIDS USEFUL IN THE TREATMENT OF DIFFERENT DISORDERS
FR15C0089I2 (en) RECOMBINATION IL-5 ANTAGONISTS USEFUL IN THE TREATMENT OF IL-5 INDUCED DISORDERS
FR2566394B1 (en) PROCESS FOR THE PREPARATION OF ACRYLIC AND METHACRYLIC ACID ESTERS BY TRANSESTERIFICATION
MA23806A1 (en) ENZYMATIC PROCESSES FOR ENRICHMENT OF POLYUNSATURATED FATTY ACIDS
EP0736545A3 (en) Dextrin ester of fatty acids and use thereof
EP0963219A4 (en) MANIPULATIONS OF NITROSING AND OXIDATIVE STRESS IN THE TREATMENT OF A DISEASE
ITPD940043A0 (en) "ACTIVE ESTERS OF CARBOXYLIC POLYSACCHARIDES"
EP0925046A4 (en) TOPICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF HEMORROIDAL PAIN
FR2566393B1 (en) PROCESS FOR THE PREPARATION OF ACRYLIC AND METHACRYLIC ACID ESTERS BY TRANSESTERIFICATION
EP0810860A4 (en) PROCESS AND USE OF RADICICOL FOR THE TREATMENT OF INFLAMMATION AND ENDOTOXEMIA
EP0485172A3 (en) Esters and amides of substituted indenyl acetic acids
FR2611729B1 (en) PROCESS FOR THE PREPARATION OF AN ACRYLATE AND / OR METHACRYLATE ORGANOPOLYSILOXANE
FR2721938B1 (en) TITANIUM AND ZIRCONIUM COMPLEXES OF CARBOXYLIC ACIDS AS CORROSION INHIBITORS
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
DK0871438T3 (en) Use of alpha hydroxy acids in the manufacture of a medicament for the treatment of inflammation
IT8948475A0 (en) L-CARNITINE ESTER WITH GAMMA-HYDROXYBUTYRIC ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT FOR THE INHIBITION OF NEURONAL DEGENERATION AND IN THE TREATMENT OF COMA
ITRM930365A0 (en) USE OF L-CARNITINE HEX ESTERS WITH AROMATIC ACIDS TO PRODUCE PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES.
FR2741355B1 (en) COMPOSITION FOR THE TREATMENT OF OBJECTS TO BE CLEANED AND / OR DISINFECTED
DE69631152D1 (en) PREVENTION OF BIOLOGICAL POLLUTION BY USING ESTERS FROM POLYGLYCOLES AND FATTY ACIDS
PL320922A1 (en) Application of mhc-ii bonding and/or somulating molecules in prevention and/or treatment of diseases involving inflammatory processes
FR2725443B1 (en) PREPARATION OF CARBOXYLIC ACIDS OR CORRESPONDING ESTERS BY CARBONYLATION IN THE PRESENCE OF IRIDIUM
FR2722798B1 (en) 1PROCESS FOR THE PRODUCTION OF OLEAGINOUS FATTY ACIDS
NO974486D0 (en) Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation
FR2747128B1 (en) PROCESS AND DEVICE FOR THE MANUFACTURE OF FATTY ACID ESTERS FROM OIL SEEDS
FR2737110B1 (en) USE OF MONOCARBOXYLIC ACIDS FOR THE TREATMENT OF KERATINIC MATERIALS